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United States Health Policies and Late-stage
Breast and colorectal cancer diagnosis: Why
such disparities by age?
Lee R Mobley1* and Tzy-Mey Kuo2
Abstract
Background: Colorectal and breast cancers are the second most common causes of cancer deaths in the US.
Population cancer screening rates are suboptimal and many cancers are diagnosed at an advanced stage, which
results in increased morbidity and mortality. Younger populations are more likely to be diagnosed at a later stage,
and this age disparity is not well understood. We examine the associations between late-stage breast cancer (BC)
and colorectal cancer (CRC) diagnoses and multilevel factors, focusing on individual state regulations of insurance
and health practitioners, and interactions between such policies and age. We expect state-level regulations are
significant predictors of the rates of late-stage diagnosis among younger adults.
Methods: We included adults of all ages, with BC or CRC diagnosed between 2004 –2009, obtained from a
newly available cancer population database covering 98 % of all known new cancer cases. We included personal
characteristics, linked with a set of county and state-level predictors based on residence. We applied multilevel
models to robustly examine differences in risk of late-stage cancer diagnosis across age groups (defined as age
65+ or < 65), focusing specifically on the effects of state regulatory factors and their interactions with age.
Results: Late stage BC diagnoses range from 24 %-36 %, while CRC diagnoses range from 54 %-60 % of newly
diagnosed BC or CRC cases across states. After controlling statistically for many confounding factors at three
levels, age < 65 is the largest person-level predictor for CRC, while black race is the largest predictor for BC. State
regulations of health markets exhibit significant interactions with age groups.
Conclusions: The state regulatory climate is an important predictor of late-stage BC and CRC diagnoses, especially
among people younger than Medicare eligible age (65). State regulations can enhance the climate of access for
younger, less well-insured or uninsured persons who fall outside normative screening guidelines.
Keywords: Late-stage cancer diagnosis; Cancer control; Health market regulation; Age disparity
Background
Colorectal cancer (CRC) is the third most common
cancer in men and women, and is the second leading
cause of cancer deaths in the United States. The risk of
CRC begins to increase after the age of 40 years and
increases more rapidly at ages 50 to 55 years. Overall,
the risk doubles with each succeeding decade, and
continues to rise exponentially [1]. The 5-year survival
rate for CRC patients is about 65 %. Colorectal cancer
incidence rates have been decreasing for most of the
past two decades, which has largely been attributed to
increases in the use of endoscopic colorectal cancer
screening tests that allow the detection and removal of
colorectal polyps before they progress to cancer. In
contrast to the overall declines, among adults younger
than 50 years, for whom screening is not routinely
recommended, colorectal cancer incidence rates have
been increasing each year since 1998 [2]. By comparison,
breast cancer (BC) is the most frequently diagnosed
cancer in women (excluding skin cancers), and ranks
second as a cause of cancer death in women. The 5-year
survival rate for BC patients is 89 %. The incidence rate
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for female breast cancer was rising until recently, due
to common use of menopausal hormone therapy, but
began to decline after publication of the landmark
Women’s Health Initiative study in 2002 [3]. Since about
2003, breast cancer incidence rates have been fairly
stable [2].
Progress has been made in the war on cancer, yet the
high proportions of late-stage diagnoses remain a public
health concern. The American Cancer Society states that
only 39 % of CRC cases are diagnosed at an early stage
[4], while about 80 % of BC cases are diagnosed at an
early stage [5]. Thus about 60 % of CRC and 20 % of BC
are diagnosed at a late stage.
National Cancer Institute statistics show that late-
stage diagnosis rates are higher among younger popula-
tions than older populations for both BC and CRC [6].
The reasons for the disparity in late-stage cancer diagno-
ses by age are not well understood. Several studies have
examined the predictors of stage at diagnosis for these
two cancers, but have not focused on age as a predictive
factor. Using SEER-Medicare data, studies have exam-
ined low SES, marital status, race or ethnicity, distance
to closest provider, managed care penetration, area
screening rates, or residence in a racially segregated
community as predictors of late-stage diagnosis [7, 8].
Other studies which examined whole cancer populations
in multiple states or regions in the US found factors
such as area poverty or deprivation, lack of personal
insurance, or percent uninsured in the area have associa-
tions with late-stage BC diagnosis [9, 10]. Another study
found that patients privately insured or insured by
Medicare plus supplemental plans had lower likelihood
of being diagnosed at advanced stages of cancer than
persons with other types of insurance, with highest rates
among uninsured and Medicaid insureds [11].
In this study, we sought to gain a more comprehensive
understanding of the predictors of late-stage cancer,
focusing on age while controlling statistically for a large
number of other factors. We use newly available data
that are representative of the vast majority of the US
to answer several new research questions, including:
Holding constant environmental factors, do the odds of
late-stage cancer diagnosis vary among people <65 and
65+, by cancer type (BC, CRC), and by state regulatory
environment? Do contextual constructs in the patient’s
residential environment predict their likelihood of late-
stage diagnosis? Holding other factors constant statisti-
cally, are state-level regulations of health insurance or
health professionals significant predictors of late-stage
diagnosis?
Methods
We examined cancer cases from the United States Cancer
Statistics (USCS) database, which is a population-based
surveillance system of cancer registries with data
representing 98 % of the U.S. population. The database
was developed by a joint effort by the Centers for
Disease Control and Prevention (CDC) and the National
Cancer Institute (NCI) to provide a single, pooled-state
database of reconciled, comparable cancer information
geocoded at the local level to facilitate cancer control
planning and evaluation [12]. This comprehensive data-
base is now available inside National Centers for Health
Statistics (NCHS) and Census Research Data Centers
(RDCs) to qualified researchers [13].
Most states participate in the USCS registry data sys-
tem, but not all allow use of county of residence infor-
mation (Illinois, Michigan, Missouri, Ohio). Three states
did not participate at all over the timeframe of this study
(Kansas, Maryland, Minnesota). We excluded these 7
states and an additional state, Virginia, because data
were not available until 2007. We also excluded Alaska
and Hawaii, because their county designations are much
different than for mainland states (each island is a
county in Hawaii, and Alaska has boroughs rather than
counties), and data are missing for some county-level
constructs. After exclusions, this resulted in 40 states be-
ing included in the analysis over the 2004–2009 period.
County level data describing contextual characteristics
of communities were obtained from the RTI Spatial Im-
pact Factor Database [14], which derives from numerous
sources. State-level data describing insurance and practi-
tioner regulatory environments were downloaded from
the National Conference of State Legislatures databases
[15, 16]. Summarizing the conceptual model: multilevel
factors including person, community, and state levels of
influence are predictors of the odds of cancer diagnosed
at an advanced stage. Data description, sources, and
brief rationale for inclusion of each covariate are pro-
vided in Table 1.
Study population
We restrict the sample to adults of all ages with a first
cancer diagnosis in 2004–2009. We excluded records
when BC or CRC were not the primary cancers, records
with unknown cancer stage or unstaged cancer, or when
diagnosis was by autopsy (<1 % of all cases). For BC we
excluded males. These restrictions yielded a CRC study
population of 558,568 individuals and a BC study popu-
lation of 981,457 individuals.
Measures
Outcome variable. Using the SEER summary stage 2000
variable provided in the database, we coded regional or
distant diagnosis as late stage, and in situ or localized
diagnosis as early stage. We then created a binary indica-
tor for each individual specifying whether their cancer
was diagnosed at a late stage, or not.
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Table 1 Multilevel Model Variables: Description, Rationale, Source, and Sample Statistics
Variable (units of measure) Rationale for Inclusion Source, date BC Models CRC Models
Outcome: whether cancer patient was diagnosed
at a late stage (regional or distant =1, else = 0)
Late stage diagnosis is indicative of lack of knowledge
regarding personal cancer risk, or the importance or
availability of screening; lack of timely or proximate
access to services, lack of funds to pay for, and cultural
or other barriers related to utilization of timely cancer
screening.
SEER and NPCR cancer registry data made available
through NCHS Research Data Centers, covering
2004–2009: http://www.cdc.gov/rdc
mean sdev mean sdev
0.308 0.461 0.543 0.498
Person-level predictors
female (binary) Only females are included in BC study. Although males
do have BC incidence, the numbers are few. Both male
and female are included in the CRC study, with male
designated as the reference group.
1.000 0.000 0.487 0.500
black (binary) The national statistics cite blacks as a disadvantaged
group, with worse outcomes relative to whites, the
reference group.
0.101 0.301 0.112 0.315
race all other (binary) All other races and ethnicities were combined to make
the model more parsimonious, relative to whites, the
reference group. Includes 8 % Hispanic, 3 % Asian, 0.5 %
Native American, 0.8 % other.
BC sample n = 981,457
CRC sample n = 558,568
0.126 0.332 0.124 0.329
age < 65 (binary) Two age groups allow us to distinguish effects for the
well-insured Medicare population from the less
well-insured younger population with cancer, who may
also be more genetically susceptible and more likely to
be screened and diagnosed at late stage.
0.624 0.505 0.424 0.494
County-level predictors
isolation black (index 0–1) Isolation indices have been examined in a broad literature
as contextual predictors of health behaviors and outcomes.
At smaller geographic scales they are thought to represent
social support, and at broader scales political clout. A higher
index value represents a lower chance that minorities reside
among whites, with a value of 1 indicating a perfectly
segregated society (2000).
RTI Spatial Database (https://rtispatialdata.rti.org)
which includes variables derived by authors under
NIH funding and made publicly/freely available.
Sources include Decennial Census 2000; CMS
Geographic Area Service Files, 2005;100 % FFS
Medicare claims extracts 2006; Census SAHIE 2005
0.257 0.214 0.259 0.217
isolation Asian (index 0–1) 0.072 0.086 0.068 0.085
isolation Hispanic (index 0–1) 0.216 0.203 0.209 0.205
managed care penetration (%) Managed care has transformed the way medicine is
practiced in highly-penetrated markets, with preventive
care services more prevalent/utilized more intensively
(2005).
15.9 14.7 15.3 14.7
Distance (miles) Calculated as the average distance (miles) over all ZIP
codes with centroid in the county to closest provider ZIP
code. Greater distance to provider of BC (mammogram)
or CRC (endoscopy) screening suggests impeded access
to preventive care services. Based on 100 % FFS Medicare
utilization of mammography or endoscopy services (2006).
6.02 6.10 5.15 4.80
Screening rate (%) Percent of the 100 % FFS Medicare population residing in
the county and alive all year that utilized cancer screening
(mammography, endoscopy) (2006).
23.60 3.18 11.05 1.43
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Table 1 Multilevel Model Variables: Description, Rationale, Source, and Sample Statistics (Continued)
Percent uninsured (%) % of the under-age-65 population who did not have health
insurance (2005).
17.73 5.45 17.75 5.49
State-level Policy Variables
Direct Access to Specialist (1 = yes, 0 = no) in 2004 Access to gastroenterologists, gynecologists or oncologists
without need of referral from a primary care physician may
result in better matching of patient/provider and more
timely care. Hypothesized to increase access for less well
insured individuals or those in more stringent managed
care plans. Younger people tend to be enrolled in these
plans, which are less costly but restrict access and choice.
Source: NCSL, 2010.
0.956 0.206 0.951 0.216
Ban on Financial Incentives (1 = yes, 0 = no)
in 2004
Not allowing insurers to reward physicians financially for
substitution of lower cost care could result in use of more
expensive cancer screening tests (e.g., colonoscopy vs
sigmoidoscopy or FOBT), more accurate surveillance and
better quality care. For BC screening, this law could impact
prescribing the more expensive MRI breast exam
recommended for denser breast tissue versus mammogram.
Source: NCSL, 2010.
0.628 0.483 0.627 0.484
Greater Practice Latitude for Nurse Practitioners
(1 = yes, 0 = no) in 2004
Allowing nurse practitioners the latitude to practice medicine
in independent clinics, without physician supervision can
improve access to primary care in underserved areas.
Hypothesized to increase access to primary care providers,
increasing the chance that a person will be encouraged to
utilize cancer screening. Source: NCSL, 2013.
0.342 0.474 0.336 0.472
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County-level contextual variables. In the 40 states,
there were 2,366 counties with outcomes data in the BC
population and 2,361 counties with outcomes in the
CRC population. We used the isolation index to measure
residential segregation of minorities from whites, which
has been shown to have social support or political influ-
ence effects in various studies [17, 18]. For measuring
accessibility, in addition to average closest distance to
provider in the county (based on 100 % FFS Medicare
service flows) we included the 100 % FFS Medicare BC
and CRC screening rates as robust county-level mea-
sures. We included managed care penetration to capture
spillovers on area practice styles, following the recent
literature which suggests there were significant man-
aged care spillover effects on the utilization of endos-
copy in 1999 [19] and its geographic availability during
2001–2005 [20]. Managed care penetration also cap-
tures urbanicity, so we included distance squared to
help capture urbanicity and better isolate the effects of
managed care. We included the percent of the under-
age-65 population who had no health insurance.
Including person and area-level factors, we are better
able to isolate the independent effects of age groups,
defined as adults over/under age 65. The vast majority
of individuals over age 65 are insured, while a lower pro-
portion of younger individuals are insured. We do not
know individuals’ insurance status, but we do control for
area percent uninsured among the population aged <65.
We interact age with state policy to determine whether
the state policy effect is different among older and youn-
ger groups.
State Regulations of Health Markets. We included three
state policy variables depicted in Figure 1, summarized in
Table 1. We hypothesize that these three state regulations
could plausibly affect the availability of information re-
garding the importance of cancer screening, or the
accessibility of specialists or physicians of choice to
better align patients with the best medical advice. Ward
et al. [11] found that people with the most preferred
types of insurance were less likely to be diagnosed with
late-stage cancer, while uninsured and Medicaid groups
were more likely diagnosed at late stage. Thus timely
Legend: (Blue=yes, White=no)
1. Direct Access to Specialist with No Referral Necessary
2. Ban on Financial Incentives to Prescribe Cheaper Services 
3. Nurse Practitioners May Practice Independently and Prescribe Medicine
1. 2.
3.
Fig. 1 Three State Regulations in 2004. Legend: (Blue = yes, White = no). 1. Direct Access to Specialist with No Referral Necessary. 2. Ban on
Financial Incentives to Prescribe Cheaper Services. 3. Nurse Practitioners May Practice Independently and Prescribe Medicine
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access to preferred physicians and specialists seems im-
portant, and state regulations that enhance this may im-
prove access; thus the first regulatory variable – Direct
Access to Specialist – is expected to enhance early-
stage diagnosis outcomes. For younger populations
lacking insurance or enrolled in more restrictive insur-
ance plans, this law would help circumvent gatekeeping
activities that might delay timely advice. The Ban on Fi-
nancial Incentives regulation is also expected to help
patients receive the best quality care, by banning the
practice by insurers of rewarding physicians financially
for prescribing lower cost alternative services. This is
expected to be especially important for CRC outcomes,
where a lower cost alternative available and prescribed
during this period – the fecal occult blood test (FOBT)
– does not prevent cancer by removing lesions in situ,
as do the endoscopy services. For BC outcomes, this
practice would perhaps inhibit prescribing MRI for
women with dense breasts in place of mammogram -
which is cheaper, but perhaps less effective.
As regards nurse practitioner (NP) scope of practice
laws - while physicians have traditionally been the main
providers of primary care services, NPs are increasingly
important in this area [21]. A systematic review of 26
studies published since 2000 found that health status,
treatment practices, and prescribing behavior were con-
sistent between NPs and physicians [22]. In areas with
greater shortages of MDs, the NPs may serve a valuable
role in providing primary care services and advice to en-
courage cancer screening and early detection. It remains
an empirical question whether these NP practice scope
regulations would have greater impact on the younger or
the older population groups, which we investigate here.
Statistical analysis
We used multilevel models to examine associations with
late stage cancer diagnosis from predictors at person,
county and state levels. We merged county-level com-
munity characteristics and state-level regulatory vari-
ables with person-level records from the USCS registry
data system (Table 1).
We specify a three-level random intercept logit model
for the late-stage diagnosis with patients nested in coun-
ties which are nested in states. We used a multilevel
modeling (MLM) framework for estimation because we
wanted to fit the regression to individuals while account-
ing for systematic, unexplained variation among counties
and states. Ignoring the county and state level effects,
when they are important, is tantamount to having
omitted variables in the model, which can bias
individual-level coefficient estimates. In addition, when
the higher-level (e.g., county) covariates are of interest,
failing to account for their structural similarity across
individuals within the counties can yield biased standard
errors for these county covariates, increasing their
apparent statistical significance [23]. Both of these con-
cerns led to the adoption of the three-level random
intercept logistic regression estimated here.
The three-level model, with the cross-level interactions
(age group and policy) across the person- and state-
levels was estimated using GLLAMM, an add-on pro-
gram to STATA (http://www.gllamm.org/). This software
is the only software package we know of that can effi-
ciently estimate a three-level random-intercepts model
with a binary dependent variable, many groups (2,366
counties, 40 states) and a large sample size (1/2 – 1
million observations), [23, 24]. We estimated the logistic
regression model of the binary cancer stage outcome
separately for each cancer type and each state policy.
The models for each cancer type used identical predic-
tors, except CRC included an indicator to differentiate
males and females.
Results
Sample statistics, Table 1: For CRC, 54 % of cases have
late stage diagnosis while for BC, 31 % of cases have late
stage diagnosis. About half of the CRC sample are
female. In both CRC and BC samples, the majority are
white. The majority of the BC sample are younger than
age 65 (62 %) whereas the opposite is true for the CRC
sample (42 % younger than age 65).
Estimation results, Table 2: Overall, the person-level
effects are quite similar across the policy models for
each cancer type. The younger age group has signifi-
cantly higher odds of late-stage diagnosis than those age
65+ in all models. Females have significantly higher odds
of late-stage CRC diagnosis than males. Blacks, or other
races or ethnicities (combined) have significantly higher
odds of late-stage diagnoses than whites across all BC
models, while only blacks have significantly higher odds
of late-stage diagnoses than whites across the CRC
models.
County contextual variables. The percentage of the
age <65 population who are uninsured is statistically
significant at the 95 % level of confidence in 5 out of 6
models, but the effect estimate is very small. Area aver-
age distance to closest provider of screening services and
its square do not have statistically significant effects in
the models. The area level screening rate was positively
associated with lower rate of late stage cancer diagnosis
for both BC and CRC. In addition, the percent of the
area population insured by managed care plans was
associated with significantly lower odds of late-stage BC
diagnosis, but significantly higher odds in one CRC
model.
Higher values of the isolation index reflect greater
isolation of the minority group from whites in their
residential settings. The isolation index for Asians is
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Table 2 Multilevel Modeling Results for Three State Regulatory Models: Predictors of Late-Stage Diagnosis of CRC
State Policy Variable: Direct Access to Specialist Ban on Financial Incentives Greater Practice Latitude NP
odds ratio p-value Lower 95 % CI Upper 95 % CI odds ratio p-value Lower 95 % CI Upper 95 % CI odds ratio p-value Lower 95 % CI Upper 95 % CI
Person level
Age < 65 1.23 0.00 1.17 1.29 1.13 0.00 1.11 1.15 1.12 0.00 1.11 1.14
Female 1.05 0.00 1.04 1.06 1.05 0.00 1.04 1.06 1.05 0.00 1.04 1.06
Black 1.09 0.00 1.07 1.11 1.09 0.00 1.07 1.11 1.09 0.00 1.07 1.11
Race all other 1.01 0.31 0.99 1.03 1.01 0.44 0.99 1.03 1.01 0.37 0.99 1.03
County level
<65 Pop uninsured 1.00 0.00 1.00 1.01 1.01 0.00 1.00 1.01 1.01 0.00 1.00 1.01
Distance to provider 1.01 0.00 1.00 1.01 1.00 0.38 1.00 1.01 1.00 0.51 1.00 1.01
Squared Distance 1.00 0.16 1.00 1.00 1.00 0.87 1.00 1.00 1.00 0.93 1.00 1.00
Screening rate 0.97 0.00 0.96 0.97 0.97 0.00 0.96 0.97 0.97 0.00 0.96 0.97
Managed care 1.12 0.01 1.04 1.21 1.02 0.64 0.93 1.12 1.06 0.20 0.97 1.17
Isolation black 0.85 0.00 0.81 0.89 0.98 0.61 0.93 1.05 0.99 0.83 0.93 1.06
Isolation Asian 1.64 0.00 1.34 1.99 1.15 0.05 1.00 1.32 1.25 0.00 1.09 1.43
Isolation Hispanic 1.04 0.28 0.97 1.10 1.05 0.24 0.97 1.14 1.01 0.78 0.93 1.10
State level
State Policy 1.00 0.98 0.95 1.05 0.97 0.05 0.94 1.00 1.02 0.16 0.99 1.04
Cross level interaction
Age <65* state policy 0.93 0.00 0.88 0.97 1.03 0.03 1.00 1.05 1.06 0.00 1.03 1.08
Random Intercept Parameters
Level 1 variance* 3.2899 3.2899 3.2899
Level 2 variance 0.0208 0.0220 0.0219
Level 3 variance 0.0041 0.0068 0.0072
*For logistic multilevel models, the variance for level one is assumed to be π2/3
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associated with significantly higher odds of late stage
CRC, and significantly lower odds of late-stage BC diag-
nosis, relative to cancer patients living in communities
with low segregation of Asians. The isolation index for
blacks is associated with significantly lower odds of
late-stage CRC diagnosis, relative to cancer patients liv-
ing in communities with low segregation of blacks, in
the first CRC model only, and these are not significant
predictors in the BC models. By contrast, living in more
isolated Hispanic communities has no significant associ-
ation with late-stage cancer diagnoses.
State insurance regulations. Our analyses found signifi-
cant interactions in all CRC models and one BC model
between age group and state policy, which is the main
focus of the paper (Tables 2 and 3). The statistical sig-
nificance of the age variable, state policy variables and
their interactions with age group shown in Tables 2 and
3 cannot be interpreted separately, because the three
variables are correlated by construction. Joint tests of
the combined effects of age group and state policy and
their interaction were statistically significant at greater
than 95 % confidence for all three models and both can-
cer types (p val < 0.05 for joint test of coefficients). To
better translate the associations between age groups and
state policy, we computed odds ratios reflecting the
different combinations of the two variables and plotted
them in Fig. 2. The “age 65+ with no state policy in
effect” is the reference group in the modeling, repre-
sented by the black-and-white striped bars’ height
meeting the axis line at ‘1’ in the figure. The under age
65 group is represented by grey and black bars, while
the age 65+ are represented by the striped and pink
bars. The figure shows that for all three policies, youn-
ger people had higher late-stage diagnosis compared to
older age groups, with or without policy. For the youn-
ger group, living in states where the first two policies
were in effect seemed to help reduce the odds of
late-stage diagnosis. For the older group, the first two
policies also seem mildly beneficial (pink bars shorter
than striped bars). For the third policy – greater prac-
tice latitude for NPs – for both age groups, the law
seems beneficial for BC but not for CRC patients.
Perhaps the advice from NPs regarding BC screening is
more uncontroversial than such advice for CRC screen-
ing, which has serious associated medical risks from the
endoscopy procedure.
The Direct Access to Specialist mandate is associated
with the most dramatic reduction in the odds of late-
stage cancers for younger people as compared to peers
in unregulated states (e.g., for CRC, odds ratios are 1.23
vs 1.14 for the younger group in states without and with
the mandate, respectively). Findings are similar for the
Ban on Financial Incentives mandate, but effects are
smaller. For both regulations, the younger group exhibits
higher odds of late-stage diagnosis for both cancers,
relative to the reference group/seniors, irrespective of
policy status.
By contrast, living in states with greater practice lati-
tude for NPs seems to benefit the younger group (1.24
falls to 1.17 in regulated states) and older age group (1.0
falls to 0.94 in regulated states) with BC. For CRC, this
policy did not benefit either the younger group (1.12 no
policy, 1.21 with policy) or the older group (1.0 no policy
and 1.02 with policy).
Robustness: Because it is difficult to ascertain overlap-
ping influences from the policies that may confound at-
tribution of policy effects to particular policies, we ran a
combined model. Combining the three policy variables
together into a single model did not diminish the statis-
tical significance of the Direct Access to Specialist policy
variable. However the Ban on Financial Incentives
became statistically weaker and NP practice latitude lost
statistical significance. However, the three were signifi-
cant as a group, and had consistent associations with
those noted above.
Estimation Diagnostics: To ascertain the importance
of information available in the random intercepts, it is
customary to look at the variance components estimated
by the model. We find that the variance of the random
intercepts at the county and state levels are very small
(bottom rows Tables 2 and 3). Two fairly recent papers
examining late-stage BC diagnosis in California used the
random intercepts multilevel model and found similarly
small variance components [25, 8]. We conclude, as they
do, that a small variance estimate for the area-level ran-
dom effects indicates that the contextual factors in-
cluded in the model do a good job accounting for spatial
heterogeneity in the explanatory factors.
Discussion/conclusions
This paper provides a comprehensive snapshot across 40
states in the US, based on fully generalizable registry pop-
ulations, to assess the importance of various predictors of
late-stage BC and CRC at first diagnosis for the period
2004–2009. The proportion of late-stage diagnosis is quite
a bit higher for CRC (54 %) than for BC (31 %) (Table 1).
These findings highlight the value of a new data resource
for comprehensive cancer control research [13].
Separate models are estimated for the person-level
odds of late-stage diagnoses for BC or for CRC. For each
cancer type, three models are run reflecting three separ-
ate state policy regulations. There are some striking
similarities in the effect estimates for each cancer type,
across the three regulatory models. Person-level effects
are quite similar across the regulatory models, and
younger age group consistently exhibits higher odds of
late stage diagnosis. Women have consistently higher
odds of late-stage diagnosis for CRC, as compared to
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Table 3 Multilevel Modeling Results for Three State Regulatory Models: Predictors of Late-Stage Diagnosis of BC
State Policy Variable: Direct Access to Specialist Ban on Financial Incentives Greater Practice Latitude NP
odds ratio p-value Lower 95 % CI Upper 95 % CI odds ratio p-value Lower 95 % CI Upper 95 % CI odds ratio p-value Lower 95 % CI Upper 95 % CI
Person level
Age < 65 1.24 0.00 1.19 1.30 1.21 0.00 1.19 1.23 1.24 0.00 1.22 1.25
Black 1.46 0.00 1.44 1.48 1.46 0.00 1.44 1.48 1.46 0.00 1.44 1.49
Race all other 1.15 0.00 1.13 1.16 1.15 0.00 1.13 1.17 1.15 0.00 1.13 1.16
County level
<65 Pop uninsured 1.00 0.02 1.00 1.00 1.00 0.01 1.00 1.00 1.00 0.34 1.00 1.00
Distance to provider 1.00 0.82 1.00 1.00 1.00 0.51 1.00 1.00 1.00 0.60 1.00 1.00
Squared Distance 1.00 1.00 1.00 1.00 1.00 0.86 1.00 1.00 1.00 0.89 1.00 1.00
Screening rate 0.98 0.00 0.97 0.98 0.97 0.00 0.97 0.98 0.98 0.00 0.97 0.98
Managed care 0.82 0.00 0.77 0.87 0.82 0.00 0.77 0.87 0.81 0.00 0.74 0.88
Isolation black 0.98 0.15 0.94 1.01 1.02 0.28 0.98 1.05 0.97 0.16 0.94 1.01
Isolation Asian 0.57 0.00 0.52 0.63 0.65 0.00 0.59 0.71 0.55 0.00 0.50 0.61
Isolation Hispanic 1.04 0.15 0.99 1.10 1.03 0.22 0.98 1.09 0.98 0.51 0.93 1.04
State level
State Policy 0.96 0.08 0.92 1.00 0.94 0.00 0.91 0.96 0.94 0.00 0.91 0.98
Cross level interaction
Age <65 * state policy 0.99 0.80 0.95 1.04 1.04 0.00 1.02 1.06 1.00 0.90 0.98 1.02
Random Intercept Parameters
Level 1 variance* 3.2899 3.2899 3.2899
Level 2 variance 0.0102248 0.01077366 0.01086441
Level 3 variance 0.00314699 0.00563015 0.00280085
*For logistic multilevel models, the variance for level one is assumed to be π2/3
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men. A higher area screening rate (for BC, CRC) is asso-
ciated with significantly lower odds of late-stage diagno-
sis for both BC and CRC (respectively).
Some interesting differences are apparent across the
BC and CRC models. Compared to CRC, the overall in-
cidence of late-stage BC diagnosis is lower, but the racial
and ethnic disparities are greater. While blacks and
other races or ethnicities (combined) have significantly
higher odds of late-stage diagnosis for BC than whites,
only blacks have significantly higher odds of late-stage
diagnosis for CRC than whites. This is puzzling, and
would be a fruitful topic of further research. Perhaps
more precise targeting of harder-to-reach minority en-
claves is warranted to reduce these disparities.
Other differences across the cancer types are at the
community level of influence, where we find several signifi-
cant factors that contribute to our understanding of these
population health outcomes. The percent of the commu-
nity population insured by managed care plans was associ-
ated with significantly lower odds of late-stage BC
diagnosis, but was not associated with significantly lower
odds of late-stage CRC diagnosis. This dichotomy may
reflect spillover effects from managed care which were ap-
parently stronger for BC than CRC screening modalities.
This would be expected, given the fact that screening
guidelines for CRC were evolving during this period, while
BC screening guidelines were well established [20].
Another interesting difference from community factors
across models is the impact of residential segregation.
For individuals living in highly segregated Asian commu-
nities, odds of late-stage BC diagnosis are significantly
lower (than for people not living in such communities)
while the opposite is true for CRC. Although it is un-
clear why, these differences may offer some insights for
local cancer control efforts, where targeting certain
populations may be of interest.
As shown in Fig. 2, the odds of late-stage diagnosis are
considerably higher for the younger (<65) than older group
(65+), and consistently so across the three state policy vari-
ables. Significant interaction effects between state policy
and age group suggest that living in states where two of
these policies have been enacted is beneficial for both
young and old, and both cancer types. For the third policy,
benefits seem evident only for BC diagnoses in both age
groups. For the first policy, Direct Access to Specialist
without a referral, the benefits in terms of odds reduction
are greater for the younger than for the older group.
People in the younger group fall outside normative
screening guidelines, and develop cancers for reasons
related to greater than average risk factors, including
genetic risk. We surmise that the younger group may
have a greater need for regulatory protection, as they
may be more financially vulnerable, and readily available
or affordable insurance coverage may have been less
Fig. 2 Odds Ratios for Late Stage Cancer Diagnosis: Age Group by State Policy Interaction, by Cancer Type
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adequate or more restrictive during this period. While we
hold constant statistically the area uninsured rate, and find
it to be a significant area-level predictor, we cannot know
the person’s insurance status. A recent study using a
different data source has shown that personal insurance is
important to protect against late-stage diagnosis, and that
not all insurances are equal in this regard [11].
We staged this study to end in 2009 so that future re-
search using the USCS database will be able to evaluate
ecological effects stemming from the passage of various
insurance regulations and their implementation, notably
the Affordable Care Act of 2010 and its provisions as they
were phased in over time. An interesting future research
question would be whether the role of area uninsured
becomes less important over time, and whether the
young-old age discrepancy and interaction with state regu-
lation becomes less pronounced. This is a fruitful area of
future research and the newly available USCS database will
be quite valuable in further explaining these disparities
and how they are impacted by policy changes.
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